Q: Further to earlier Q,Fabrice Taylor reported that new investors led the Bitove family have taken over CLIQ plus ACB's 25%@ $15.What is the % of Bitove? Txs for u usual great services & views
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I currently own PHO and down quite a bit and my weight is now only 1.50 % would you be comfortable buying enough to bring to a 2% weight or best to wait until we see this sector moving again?
Thanks
Thanks
Q: I have a small position in MTY. May I get your analysis of the latest quarterly results. Is MTY worth keeping? I am a growth oriented investor.
Thanks.
Thanks.
Q: Goodmorning
We have wpk in our TFSA what are your thoughts of selling it and replacing it with rpi for better growth and higher dividend?
M
We have wpk in our TFSA what are your thoughts of selling it and replacing it with rpi for better growth and higher dividend?
M
Q: I've been watching Stella lately, and am wondering with the drop today (on news of the CEO resigning, I think), would this be an opportunity to add to an existing position - Thanks as ususual...
Q: Views on departure go CEO. How significant is this?
Q: LSPD slided close to $4 from July 5 to 9(c $38.18) after reaching 443.105 H. Its CEO appeared @8.45am ET today on BNN & this appears to have a positive impact(current $39.98 + $1.80) Your thoughts of the interview.Is it OK to add some more(thanks to for rec @ $28.12,I bought @ $28.72(2.5% pos. & now it is 4%))? Txs for u usual great services & views
Q: Raymond James has $33 price target for Lspd, but the stock price right now is in $40. Your thoughts please.? Would you buy at current price? Thanks
Q: Even with good news that Star Group, Akwesasne enter N.Y. Sports betting deal but why stock price still drifting lower? Your thoughts please, thanks
Q: I noticed that SJ last report was in January 2018. Will there be a update soon on this stock? The last time you downgraded and just wonder if you would still maintain the same rating or downgrade it again? Would you be a buyer of this stock?
Thanks
Thanks
Q: NFI seems to have a good backlog of orders; why is it still struggling? Still a good hold?
Q: What will it take to get rid of this Meir guy? I thought the results of last meeting's votes were the end of this nonsense. His childish attacks and lying news releases are an embarrassment. Is he 10 years old or something? Is he mentally challenged or is he just a terrible person? Obviously Jonny G and the Knight team made a big misstep partnering with this clown. Does Medison (ultimately Knight) pay for these spurious news releases? How is this not slander? What is Knight to do?
Q: I have been unable to locate the LSPD vs Peers report on your site. Help please
Q: I copy that Spin Master is debt-free and has been through a recent rough spot. It seems 5i continues to endorse it. What would it take for 5i to indicate that it is broken?
Q: Good morning team,
Re: Gud's NCIB:
“Be mindful that the largest beneficiary of the share repurchase program is Jonathan Goodman. Even if he does not participate, the reduction of shares at a substantial discount to last $10 per share capital raise only serves to increase his percentage control of the company. Like his conflicting interests with his family business (Pharmascience), either way he wins and shareholders lose.
“Rather than engage in financial engineering that principally benefits the CEO, why didn’t the Board consider a partial tender offer for shares at $10? Just give shareholders their money back at the price paid? It’s a fair question. But one that we fully expect the company to ignore.
https://ca.finance.yahoo.com/news/medison-biotech-jonathan-goodman-takes-124100485.html
Comments please,
Thank you!
Re: Gud's NCIB:
“Be mindful that the largest beneficiary of the share repurchase program is Jonathan Goodman. Even if he does not participate, the reduction of shares at a substantial discount to last $10 per share capital raise only serves to increase his percentage control of the company. Like his conflicting interests with his family business (Pharmascience), either way he wins and shareholders lose.
“Rather than engage in financial engineering that principally benefits the CEO, why didn’t the Board consider a partial tender offer for shares at $10? Just give shareholders their money back at the price paid? It’s a fair question. But one that we fully expect the company to ignore.
https://ca.finance.yahoo.com/news/medison-biotech-jonathan-goodman-takes-124100485.html
Comments please,
Thank you!
Q: What's the Street expectations of upcoming Q.?Your expectations & opinion.Thanks for u usual great services & views(yesterday wrongly asked about TM,should be TOY)
Q: Would you have a stop loss on these companies? My worst performers by far -20% and -30% in each. Are insiders selling or have a low position? What is the short position in each company. Thanks
Q: Do you see any reason for the big drop today?
Q: Thoughts?
http://www.globenewswire.com/news-release/2019/07/08/1879781/0/en/Knight-Announces-Normal-Course-Issuer-Bid.html
http://www.globenewswire.com/news-release/2019/07/08/1879781/0/en/Knight-Announces-Normal-Course-Issuer-Bid.html
Q: It keeps beating expectations,why it has not shot up?What are the Street & your expectations of the upcoming Q? Txs for u usual great services & expectation. Very sad news-K Leonard is gone from NBA champ.Raptors